Roivant Sciences (ROIV) Short-Term Debt issuances (2020 - 2022)

Roivant Sciences (ROIV) has reported Short-Term Debt issuances for 3 consecutive years, with $159.9 million the latest figure, recorded in Q4 2022.

• For the quarter ending Q4 2022, Short-Term Debt issuances rose 339.28% year-over-year to $159.9 million; the trailing twelve-month figure through Dec 2023 stood at $159.9 million (down 55.11% YoY), and the FY2023 full-year result was $159.9 million, up 339.28% from the prior year.
• Short-Term Debt issuances was little changed at $159.9 million in Q4 2022 per ROIV's latest filing, from $159.9 million in the prior quarter.
• Across five years, Short-Term Debt issuances topped out at $159.9 million in Q2 2022 and bottomed at -$36.4 million in Q4 2020.
• Historically, Short-Term Debt issuances has averaged $71.2 million across 3 years, with a median of $36.4 million in 2021.
• The sharpest annual moves came in 2021 and 2022: Short-Term Debt issuances soared 200.0% in 2021, then jumped 339.28% in 2022.
• Over 3 years, Short-Term Debt issuances stood at -$36.4 million in 2020, then jumped by 200.0% to $36.4 million in 2021, then jumped by 339.28% to $159.9 million in 2022.
• According to Business Quant data, Short-Term Debt issuances over the past three periods registered $159.9 million, $159.9 million, and $36.4 million for Q4 2022, Q2 2022, and Q4 2021 respectively.